Background and Purpose-Because the new era of preclinical stroke research demands improvements in validity and generalizability of findings, moving from single site to multicenter studies could be pivotal. However, the conduct of magnetic resonance imaging (MRI) in stroke remains ill-defined. We sought to assess the variability in the use of MRI for evaluating lesions post stroke and to examine the possibility as an alternative to gold standard histology for measuring the infarct size. Methods-We identified animal studies of ischemic stroke reporting lesion sizes using MRI. We assessed the degree of heterogeneity and reporting of scanning protocols, postprocessing methods, study design characteristics, and study quality. Studies performing histological evaluation of infarct size were further selected to compare with corresponding MRI using meta-regression. Results-Fifty-four articles undertaking a total of 78 different MRI scanning protocols met the inclusion criteria. T 2 -weighted imaging was most frequently used (83% of the studies), followed by diffusion-weighted imaging (43%). Reporting of the imaging parameters was adequate, but heterogeneity between studies was high. Twelve studies assessed the infarct size using both MRI and histology at corresponding time points, with T 2 -weighted imaging-based treatment effect having a significant positive correlation with histology ( R 2 0 699 = .
1
M any drugs have been tested in animal studies of focal cerebral ischemia, but despite this few interventions of proven efficacy are available and tissue-type plasminogen activator is the only approved drug for clinical use during the acute phase. 1, 2 Three major factors are likely to have contributed to this translational roadblock. First, weaknesses in the design of animal studies, such as threats to their internal validity by the lack of blinding and randomization, and low statistical power, may have caused interventions to seem falsely efficacious. Second, clinical trials may have been designed to test efficacy in conditions where efficacy had not been previously demonstrated in preclinical studies, for example, in comorbid patients or substantially longer time to treatment than used in the animal studies. Third, pathophysiological differences between animal and human stroke may lead to a lack of fidelity of the stroke models themselves limiting their usefulness. [3] [4] [5] Multicenter preclinical trials could increase the validity and generalizability of experimental findings by combining measurements from different centers, 6, 7 but the inherent variability in methodological approaches should first be addressed before implementing such studies. The recent publication of guidelines for the reporting of animal research is a step forward 8 ; however, little consideration has been given to the use and reporting of imaging in animal stroke studies.
Magnetic Resonance Imaging (MRI) is an invaluable and versatile imaging tool used in both clinical and preclinical research. In stroke, diffusion-weighted imaging (DWI) and perfusion imaging are sensitive to the consequences of early ischemia by detecting subtle changes in the diffusion of water or the hemodynamic status of injured brain, respectively. This information can be used in the laboratory for confirmation of occlusion, localization and tracking of the evolving ischemia, or prognosis of late outcome. [9] [10] [11] [12] Conventional MRI, such as T 2 -weighted imaging (T2WI), is less sensitive to acute changes in the ischemic brain and is usually performed late to identify the extent of neuronal death (infarct). 9, 10, 13 Traditionally, experimental stroke studies have used ex vivo histological analysis of the latter.
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arbitrary time point after the induction of ischemia; the choice of this time point is critical because brain injury post stroke is a spatiotemporally evolving process. 13 MRI, in contrast, allows longitudinal assessment of the developing lesion in vivo and estimation of treatment effect in the same cohort of animals.
With the advent of high-resolution scanners for small animal imaging, MRI has now become a routine modality in many preclinical centers and the establishment of a standard approach to its use seems more imperative than ever. In addition, although several studies reported equivalence between MRI and histological infarct size measurements in rodents post stroke, [16] [17] [18] a more robust assessment by comparing lesion-based treatment effects from multiple studies could be useful. The principal aim of this study was to review variability in the use of MRI in studies of focal cerebral ischemia and to identify the different postprocessing methods for the quantification of visible lesion sizes post stroke. We also set out to examine the association between histological outcome, the current gold standard for assessing infarct size, and the different MRI techniques using meta-regression, to assess the performance of the modality as an infarct size biomarker in animal studies of stroke.
Methods
Identification of Relevant Studies
Since 2004, the Collaborative Approach to Meta-Analysis and Review of Animal Data in Experimental Studies (CAMARADES) have been conducting systematic reviews of interventions tested in animal models of stroke. The CAMARADES database holds details of 1824 publications describing 5329 experiments testing the efficacy of candidate drugs in focal cerebral ischemia. For systematic review, we identified (April 30, 2014) studies that used MRI to quantify tissue injury and screened the full text to select controlled animal studies of focal cerebral ischemia, which determined the lesion size in vivo using MRI and reported measurements in text or graphically. We included studies published in any language. To examine how MRI outcome compares with histologically measured outcome by means of meta-analysis, we selected only the studies that reported infarct sizes using histology in the same cohort of animals where MRI was used.
Data Extraction
We recorded details related to animal handling for MRI (positioning method in scanner, anesthetic used, and physiological parameters monitored), scanning protocol (scanner field strength and manufacturer, type of radiofrequency coil, pulse sequence type and parameters, and scan duration), and postprocessing method for lesion size measurement (software and method used, blinding, and analysis by multiple observers) for all identified studies. We also extracted the animal species, the type of ischemia, the intervention tested, the ischemic side of brain and the respective artery, which was occluded. Study quality was assessed using a 10-item checklist. 19 For meta-analysis, we recorded infarct size measurements (mean and a measure of variance, number of animals per group) for both MRI and histology measures for both treatment and control groups. Where data were not given in the text, we used values previously recorded in the database (based on requests to authors or measurement from figures if contact with authors was unsuccessful). Where studies used multiple treatment groups, we divided the number of animals in the control group by the number of treatment groups served for the purposes of meta-analysis.
Data Analysis
We categorized experiments by individual imaging and study design parameters and calculated the percentage of studies reporting each.
Because certain aspects of MRI are influenced by the animal species used, we calculated the range and the median value of continuous imaging variables separately for each species. Where parameters were reported in different units, we converted them to the same scale.
For meta-analysis, we calculated treatment effects measured using MRI and histology as a normalized mean difference, 20 the percentage improvement in the treated cohort. We used the DerSimonian and Laird random effects meta-analysis 21 to pool treatment effects because we anticipated substantial heterogeneity between studies. The significance of heterogeneity between k groups/comparisons was assessed using the χ 2 distribution with k−1 degrees of freedom. 20 We used meta-regression (function metareg in Stata version 13; StataCorp ® , College Station, TX) to assess the relationship between effect sizes determined histologically and by MRI. 22 The proportion of the variance in the dependent variable (histological outcome) that is explained by variation in the independent variable (MRI) is indicated by an adjusted coefficient of determination, R 2 . We then included the time of outcome assessment as a regression covariate. Statistical significance was set at P<0.05.
Results
We identified 57 studies using MRI, of which 2 did not report measurement of lesion size and 1 performed ex vivo MRI; therefore, we extracted data from 54 studies, published between 1994 and 2010 ( Figure 1 ; included articles are listed in Table I in the online-only Data Supplement). One study (2%) was published in Chinese and was translated into English. Two (4%) were published in abstract only and were cross-checked to verify that the data were not later published in full to ensure that we did not include duplicate data. Most studies used rats (42; 78%), 11 used mice (20%), and 1 used baboons (2%). Forty-five studies used T2WI (83%), 23 used diffusion-weighted imaging (43%), 4 used T1WI (7%), 3 used perfusion imaging (6%), 2 used plasma volume imaging (4%), and 1 did not state the weighting applied (2%); overall there were 78 different scanning protocols, with 19 studies (35%) reporting >1 method for assessing lesion size.
Study Quality
The median number of study quality checklist items scored was 4 (range, 0-6; Figure 2 ). Few studies reported blinding the induction of ischemia (4%), a statement of potential conflicts of interest (6%) or the use of animals with comorbidities (4%), and no study reported a sample size calculation. Random allocation to group was reported in 18 studies (33%) and the blinded assessment of outcome in just 9 studies (17%), despite the fact that a few other studies reported blinding of the assessment of outcomes other than MRI. Reporting of control of animals' temperature during surgery, compliance with animal welfare regulations, and the use of an anesthetic without known neuroprotective activity before or during outcome assessment were prevalent in the majority of reviewed articles (76%, 70%, and 63%, respectively). Figure 3 shows the level of reporting of various MRI items in reviewed articles. Reporting was adequate for most items, particularly those relevant to the scanning protocol. However, parameters indicative of the quality of imaging methodology (monitoring of animals' physiological parameters during scanning and analysis of data by multiple observers) were the least commonly reported in examined articles. Heterogeneity in the design of MRI between studies was high, with a wide range of anesthetics, scanner equipment manufacturers, scanner field strengths, and radiofrequency coil types recorded (Table II in the online-only Data Supplement). Studies were performed on systems with field strengths ranging from 1.5 to 9.4 Tesla, with 4.7 and 7 Tesla animal scanners being the most prevalent (29% each). Volume coils were preferred for signal transmission and reception (55%), followed by surface coil or a combination of both types (23% each). Several studies reported the use of anesthetic or radiofrequency coil without providing details. Of 54 studies, only 16 stated monitoring of physiological parameters during scanning, with temperature having the highest prevalence among reported parameters (82%). In 12 studies, the side of the stroke was not reported, and in many others it had to be derived indirectly. In some studies, the stroke side on exemplar images conflicted with that reported in the text, introducing confusion in the interpretation of results.
MRI Acquisition and Postprocessing Parameters
There was a large range of acquisition parameters for the 2 most common MRI signal-weightings (T2WI, DWI; Table 1 ). For example, for T2WI of rats, echo time ranged from 30 to 120 ms, the number of slices from 6 to 35, the slice thickness from 0.35 to 3 mm, the field of view from 22×22 to 120×120 mm 2 , and the matrix size from 64×64 to 512×512. For mouse imaging, the range was usually narrower although median values were similar. For DWI, details of the applied diffusion-sensitizing gradients were seldom reported, except for the b-factor, which ranged from 20 to 1898 s/mm 2 for rat imaging and 70 to 1224 s/mm 2 for mouse imaging. Unexpectedly, the type of pulse sequence was reported for only slightly over half of recorded protocols (29 T2WI protocols, 64%; 12 DWI protocols, 52%). The most commonly used types for T2WI were conventional spin echo and fast spin echo with 14 protocols each; 1 study used fluid-attenuated inversion recovery spin echo imaging. For DWI, conventional spin echo (6 protocols), spin echo echoplanar imaging (4 protocols), stimulated echo (1 protocol), and fast spin echo sequences (1 protocol) were reported. Despite the variety of pulse sequences, there was a similar prevalence of reporting and range of parameter values for these techniques. For larger scanner field strengths, echo time tended to be shorter and acquired slices thinner, but the majority of recorded parameters were not found to be dependent on field strength. Finally, the duration of the scanning protocol per animal was reported in a small number of studies (7 T2WI protocols, 16%; 2 DWI protocols, 9%). The median duration for T2WI in rats was 7.5 (range, 1.1-9) minutes and in mice was 5 minutes (no range recorded), whereas DWI usually took longer (median, 11 [range, [7] [8] [9] [10] [11] [12] [13] [14] [15] minutes in rats; no data given for mice). Lesions in MRI images were assessed using a range of commercially available (83%) or home-made (17%) tools. Methods for determining the extent of the lesions were recorded separately for each scanning protocol; semiautomated analysis using thresholds was performed for the majority of protocols (76%), followed by manual delineation (20%) and other automated methods (4%). Of 45 recorded T2WI protocols, 44 were applied during the first few days after ischemia when brain edema significantly contributes to the visible hyperintensity in acquired images; only 11 of these (25%) used a method for taking into account its presence. Nine of the postprocessing protocols that applied an edema correction for estimating the infarct size used the method proposed by Swanson et al, 23 whereas 2 studies normalized the observed lesion size by the ratio of the hemispheric volumes. Lesion size was presented in published reports using a variety of measures, with volume in cubic millimeters being the most frequent. -indicates that the value cannot be calculated; FLAIR, fluid-attenuated inversion recovery; FSE, fast spin echo; MRI, magnetic resonance imaging; N, total number of protocols for which the parameter is relevant; n, number of protocols for which the parameter is reported; N/A, not applicable; and N/G, not given.
*Multiple values have been used for these parameters in some protocols. If only the range was reported, the minimum and maximum values were incorporated into the calculated range but they were excluded from the calculation of the median value.
†A representative range was estimated by sorting the products of each pair of values. The most frequently reported value is given instead of the median. ‡Parameters applicable only to specific types of sequences. 
Meta-Analysis
Fifteen publications assessed infarct size post treatment using both MRI and histology (28%). In 2 of these, there was a substantial delay between MRI scanning and histological assessment and in 1 study data for a control group were not provided ( Figure 1 ). Of 12 remaining studies (46 comparisons, n(animals) MRI =428, n(animals) hist =228), 11 performed T2WI (33 comparisons, n(animals) T2WI =410, n(animals) hist =210) and 6 performed DWI (11 comparisons, n(animals) DWI =147, n(animals) hist =105) immediately before sacrifice. These comparisons were used for metaregression. Only 1 study reported T1WI and perfusion imaging (1 comparison each, n(animals) MRI =19, n(animals) hist =19) alongside histology 24 ; therefore, we were unable to assess the relationship between histology and these specific imaging methods. Histological assessment of infarct size was performed with 2,3,5-triphenyltetrazolium chloride staining in 10 studies, haematoxylin and eosin staining in 1 study, and cresyl violet staining in another one. All included studies involved rats, except one that used mice.
Overall, all imaging findings explained 56.6% of the observed variation in histological outcome (P<0.001), as shown in Table 2 . This relationship was stronger for T2WI ( R ; P=0.079; coefficient, 0.36; 95% CI, −0.05 to 0.78). Overall, T2WI estimated an improvement in lesion size of 22.2% (95% CI, 17.9%-26.6%) in the treatment group when compared with that of 25.5% (95% CI, 17.5-33.5) when outcome was measured histologically in the same cohorts of animals ( Table 2 ). The improvement in lesion size for DWI was 42.4% (95% CI, 30.9-54.0) when compared with 31.8% (95% CI, 24.0-39.7) when measured histologically.
Discussion
We have shown substantial variability in the selection of scanning parameters and postprocessing methods used to assess lesion size in experimental focal cerebral ischemia and in the quality of published reports. Reporting of MRI methodology was assessed against several important items covering the animal handling procedures for imaging, the scanning protocols and the postprocessing methods for estimation of lesion sizes. We think that these constitute the minimum set of information that should be present in reports of experimental studies of stroke using MRI; yet, no study fulfilled this duty to the maximum extent. There was generally adequate reporting of scanner equipment manufacturer, scanner field strength, TR, echo time, and slice thickness, but not of the method of animal positioning in the scanner, monitoring of physiological parameters, methods for improving analysis validity (blinding and multiple observers), scan duration, or pulse sequencespecific parameters. The diverse range of scanner vendors, scanner field strengths, coils, and postprocessing software is not in itself a cause for criticism, but given that in clinical research such variability can have profound effects on measured outcome, [25] [26] [27] it seems reasonable to assume that it might also affect lesion size measurement in animals. The significant variability in MRI protocols and postprocessing methods raises questions about which approach is best for each contrast technique, and whether results from different studies are comparable. Furthermore, in our review, we identified only 1 study reporting that image analysis was performed by 2 independent observers, whereas in only 9 of 54 studies did the Effect size based on T2−weighted imaging (%) Figure 4 . Meta-regression of the effect size estimated from histological and T 2 -weighted imaging infarct size measurements at corresponding time points. The size of the circles reflects the precision of each estimate; large circles mean small SE and thus larger weight in the regression (y=1.08x + 2.10; R -2 = 0.699). 28 ) , raising concerns about the presence of detection bias and introducing dubiety to reported outcomes. On the basis of these observations, we are unable to make recommendations for the best neuroimaging method to assess lesion size for each MRI technique. It should be acknowledged, however, that the optimal scanning protocol must be a compromise between resolution, anatomic coverage, contrast between normal and injured tissue, and speed, to allow accurate quantification of lesion size, while minimizing the duration of anesthesia received by animals for MRI. The selection of parameters' values, in turn, might depend on the animal species, the scanner field strength and the imaging technique used, as found in this review.
We assessed reported study quality using our standard approach 19 and found poor reporting of items, despite several contemporary recommendations including Stroke Therapy Academic Industry Roundtable-I 2, 29 ; experimental stroke studies that do not report such measures may overstate treatment effects. 4 Unfortunately, no standard criteria for assessing the quality of imaging in animal studies exist in the literature. The effect of individual parameters to the quantification of lesion sizes and subsequently treatment effects should first be explored before checklists for robust MRI quality assessment are formed. The diversity of experimental protocols (different species, stroke models, drugs, and treatment regimens) identified here precluded analysis of the effect of study design items or of any basic imaging parameters; segregation of studies by various criteria sometimes led to groups consisting of a single study.
In contrast, in our analysis of alternative approaches to measuring the infarct size, the observed heterogeneity is not a concern because study characteristics and design were matched across the 2 outcome measures. We accounted for heterogeneity between studies in our calculation of summary estimates by using random-effects meta-analysis. The inclusion of measurements from a range of time points post stroke (48-336 hours for T2WI and 21-174 hours for DWI) is useful in capturing evolving changes in outcome, but may have been misleading if the relationship between measurements at different time points was influenced by different pathophysiological indicators. Indeed, the inclusion of time in the regression model improved its performance, suggesting that this may well be the case. Such observation is in agreement with studies reporting that neuronal death is an evolving process, 13, 30 indicating that the selection of a time point for estimation of treatment effects based on infarct size is crucial. Although it is more convenient for studies to use earlier time points to avoid sample size shrinking because of animal death and reduce study costs, treatment effects might become less useful when measured early. The more pronounced effect on histology-DWI regression could imply that the use of this MRI technique during the considered time period is an unreliable indicator of the effectiveness of tested interventions. However, the small number of comparisons included in this analysis precludes the extraction of safe conclusions. Furthermore, we assumed equivalence of the different histological measures of infarct size, 16, 31, 32 and this may also have confounded our findings.
Notwithstanding these concerns, our findings suggest that T2WI can be used effectively as an in vivo noninvasive alternative assessment of infarct size, at least ≤2 weeks after the onset of ischemia. Indeed, the confidence limits of the summary assessments suggest that this approach may have greater statistical power when compared with histology (and hence require fewer animals). This does not imply that T2WI provides an equivalent estimate of infarct size, and in fact reported infarct volumes (as distinct from treatment-related effect sizes) were larger for T2WI than for histology in both treatment and control groups. This may be because none of the included studies applied a correction to take into account the accumulated vasogenic edema on T2WI, which slightly decreases in histological slices because fixation may shrink the lesioned tissue. 16, 18 DWI hyperintensity did not correlate well with the histological lesion, giving larger estimates of effect size. This may be because DWI is sensitive to the restricted diffusion of extracellular water because of the abnormal swelling of cells (cytotoxic edema) at the early stages of stroke progression [9] [10] [11] [12] ; diffusion lesions were larger than postmortem stained lesions at 21 hours (1 comparison) and smaller between 168 and 174 hours after stroke (9 comparisons), suggesting an early effect of cytotoxic edema.
To our knowledge, this is the first systematic review and meta-analysis of MRI in experimental stroke. It lacks, however, specificity by including studies using any MRI technique for assessing lesions at any time point. Our primary objective was to provide an overview of the use of the modality in preclinical stroke research and examine whether this could be a limiting factor in data pooling in meta-analyses or multicenter animal studies; our findings clearly support this hypothesis. Additional studies should focus on individual MRI techniques or outcomes. Rivers and Wardlaw 30 reviewed the use of DWI in animal studies of focal cerebral ischemia and identified incomplete reporting of experimental details. They also examined whether DWI could provide information on tissue viability by comparison with various histopathologic markers, but their assessment was limited in description of findings reported in included articles. Dani et al 33 assessed the reporting of perfusion imaging in human stroke and found a similar poor consistency between studies. Perfusion imaging coregistered with diffusion imaging is a technique for identifying the salvageable tissue (represented by the mismatch of the 2 images), which provides a hypothetical target for reperfusion therapies. The concept of an ischemic penumbra has been subject to significant scrutiny in both clinical and preclinical research but no widely accepted definition. 34 This could explain, in part, the small number of perfusion imaging protocols recorded in our review. There have been calls for consensus in the use of perfusion-diffusion imaging for defining the penumbra in humans and in animals, 11, 30 which we support. However, there is a more pressing case, demonstrated here, for consensus in the use of more routine MRI techniques.
A further weakness of this study is that we included data from a single database comprising a nonexhaustive list of animal studies limited to interventions, which had been assessed using systematic review. However, contributing 
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March 2015 studies were identified using systematic search strategies, collected without consideration of the imaging methodology used. Therefore, the articles examined in this review can be considered representative of experimental stroke imaging studies in the literature. Few experiments assessed infarct size using both histology and MRI (46 of 5329 experiments), and this did not allow exploration of any effect imaging parameters have on the relationship between MRI and histological outcome measures. A systematic review seeking to identify all such studies would enable such an analysis, but it is likely to require screening of a large number of publications.
Conclusions
We show substantial variability between studies in the use of MRI for the assessment of lesion size. Strong correlation between histology and T2WI suggests that optimization of a T2WI scanning and postprocessing method for quantification of final infarct size is feasible. Guidelines for the use and reporting of methodology are needed, similar to those developed for the conduct of human stroke imaging. 35, 36 This would permit exact replication of the experiments and analyses and would support the use of imaging end points in multicenter animal studies. Table II . Reporting and details of basic characteristics of the imaging procedure n indicates the number of protocols for which the parameter is reported; N, total number of protocols for which the parameter is relevant; T, tesla; , size of contralateral hemisphere; , size of ipsilateral hemisphere; , size of visible lesion in .
Sources of Funding
*Post-processing parameters, applicable to each of the 78 imaging protocols. †Applied on T 2 -weighted images acquired at the acute to subacute stages of stroke (relevant to 44 out of 45 protocols).
Parameter Reported, n/N (%) Not Reported, n/N (%)
Details of reported parameters, n/N (%)
